CTNM Revenue

CTNM Annual Revenue

$50.00 M
0.00%

31 December 2023

All-time High

$50.00 M
CTNM annual revenue is currently at an all-time high

Sector Rank

47.17%
CTNM annual revenue is higher than 47.17% of companies in Healthcare sector
Price$11.77
CTNM price is $11.77
Annual EPS$1.12
CTNM annual earnings per share is $1.12
Annual Operating Profit$16.08 M
CTNM annual operaing income is $16.08 million
Annual Net Income$22.72 M
CTNM annual net profit is $22.72 million

CTNM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTNM Quarterly Revenue

N/A

30 September 2024

All-time High

$50.00 M
CTNM quarterly revenue is currently at an all-time high
Price$11.77
CTNM price is $11.77
Quarterly EPS-$0.40
CTNM quarterly earnings per share is -$0.40
Quarterly Operating Profit-$12.97 M
CTNM quarterly operating income is -$12.97 million
Quarterly Net Income-$10.27 M
CTNM quarterly net profit is -$10.27 million

CTNM Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTNM TTM Revenue

N/A

30 September 2024

All-time High

$50.00 M
CTNM TTM revenue is currently at an all-time high
Price$11.77
CTNM price is $11.77
TTM EPS-$0.42
CTNM TTM earnings per share is -$0.42
TTM Operating Profit-$43.52 M
CTNM TTM operating income is -$43.52 million
TTM Net Income-$35.46 M
CTNM TTM net profit is -$35.46 million

CTNM TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTNM Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

CTNM Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-yearat highat low
alltimeall timeat highat low

Contineum Therapeutics Class A Revenue History

DateAnnualQuarterlyTTM
Dec 2023
$50.00 M
-
-
DateAnnualQuarterlyTTM
June 2023
-
$50.00 M
$50.00 M

FAQ

  • What is Contineum Therapeutics Class A annual revenue?
  • What is the all time high annual revenue for Contineum Therapeutics Class A?
  • What is the all time high quarterly revenue for Contineum Therapeutics Class A?
  • What is the all time high TTM revenue for Contineum Therapeutics Class A?

What is Contineum Therapeutics Class A annual revenue?

The current annual revenue of CTNM is $50.00 M

What is the all time high annual revenue for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high annual revenue is $50.00 M

What is the all time high quarterly revenue for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high quarterly revenue is $50.00 M

What is the all time high TTM revenue for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high TTM revenue is $50.00 M